<DOC>
	<DOCNO>NCT01829087</DOCNO>
	<brief_summary>The goal research project evaluate injection botulinum toxin A ( Botox ) treatment knee flexion contracture total knee arthroplasty ( TKA ) . The current treatment patient achieve full extension knee ( flexion contracture ) TKA consist aggressive physical therapy program , home stretch program , use extension orthosis ( brace ) . Many patient tolerate wear brace . This initial project design use injection Botox adjunct standard current treatment evaluate efficacy . It hypothesis single injection hamstring addition routine postoperative rehabilitation result improve knee extension improvement function endure without treatment .</brief_summary>
	<brief_title>Botulinum Toxin A Treat Flexion Contracture After Total Knee Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Contracture</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Subject least 18 year age Subject total knee replacement total knee replacement revision surgery perform Main Line hospital Bryn Mawr Hospital , Lankenau Hospital , Riddle Hospital Subject measure least 10 degree flexion contracture operative knee four six week follow surgery Subject willingness complete schedule follow evaluation describe informed consent Subject currently involve another study receive investigational product treatment within last 30 day Subject prisoner Subject anticipate noncompliant Subject know pregnant Subject mentally incompetent unable understand participation study entail The subject know sensitivity allergic reaction Botulinum Toxin A albumin The subject unwilling unable give consent comply follow program</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>